DK1000067T3 - Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne - Google Patents

Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne

Info

Publication number
DK1000067T3
DK1000067T3 DK98940327T DK98940327T DK1000067T3 DK 1000067 T3 DK1000067 T3 DK 1000067T3 DK 98940327 T DK98940327 T DK 98940327T DK 98940327 T DK98940327 T DK 98940327T DK 1000067 T3 DK1000067 T3 DK 1000067T3
Authority
DK
Denmark
Prior art keywords
compounds
thiazolobenzoheterocyclic
preparation
drugs containing
preparing
Prior art date
Application number
DK98940327T
Other languages
English (en)
Inventor
Jean-Claude Hardy
Jean Bouquerel
Patrick Nemecek
Jean-Francois Peyronel
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1000067T3 publication Critical patent/DK1000067T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
    • C07D517/06—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98940327T 1997-07-28 1998-07-24 Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne DK1000067T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709556A FR2766487B1 (fr) 1997-07-28 1997-07-28 Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
PCT/FR1998/001638 WO1999005147A1 (fr) 1997-07-28 1998-07-24 Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant

Publications (1)

Publication Number Publication Date
DK1000067T3 true DK1000067T3 (da) 2003-02-24

Family

ID=9509694

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98940327T DK1000067T3 (da) 1997-07-28 1998-07-24 Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne

Country Status (25)

Country Link
US (1) US6369221B1 (da)
EP (1) EP1000067B1 (da)
JP (1) JP4491131B2 (da)
KR (1) KR100621703B1 (da)
CN (1) CN1122670C (da)
AT (1) ATE226585T1 (da)
AU (1) AU746193B2 (da)
BR (1) BR9811056A (da)
CA (1) CA2298974C (da)
CZ (2) CZ2000194A3 (da)
DE (1) DE69808922T2 (da)
DK (1) DK1000067T3 (da)
ES (1) ES2187997T3 (da)
FR (1) FR2766487B1 (da)
HU (1) HU226210B1 (da)
IL (4) IL134192A0 (da)
NO (1) NO314630B1 (da)
NZ (1) NZ502054A (da)
PL (1) PL195758B1 (da)
PT (1) PT1000067E (da)
RU (1) RU2198889C2 (da)
SK (1) SK285767B6 (da)
TW (1) TW570923B (da)
WO (1) WO1999005147A1 (da)
ZA (1) ZA986680B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307067D0 (en) 2002-12-17 2003-04-30 Aventis Pharma Inc Use of thiazolobenzoheterocycles for treating multiple sclerosis
FR2863612B1 (fr) * 2003-12-12 2006-03-03 Aventis Pharma Sa PROCEDE DE FABRICATION DE PRODUIT DE TYPE THIAZOLO[3,4,5-de] [4,1]BENZOTHIAZEPINE
US7179909B2 (en) 2003-12-12 2007-02-20 Aventis Pharma S.A. Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type
FR2867187B1 (fr) * 2004-03-02 2007-10-12 Centre Nat Rech Scient Procede utile pour la preparation de benzazepines et derives de celles-ci.
CA2918708C (en) * 2013-07-22 2021-07-06 Sumitomo Chemical Company, Limited Plant fungal disease control composition and its use
ES2731349T3 (es) * 2013-07-22 2019-11-15 Sumitomo Chemical Co Composición para el control de enfermedades de las plantas y su uso
US9781931B2 (en) 2013-07-22 2017-10-10 Sumitomo Chemical Company, Limited Plant disease control composition and its use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173701A (en) * 1967-03-24 1969-12-10 Smith Kline French Lab 5-Substituted-1,4-Benzodiazepines
US3794646A (en) * 1970-04-14 1974-02-26 Robins Co Inc A H 5,7-disubstituted-1,9-tetramethylene-1,4-benzodiazepin-2-ones
US3857854A (en) * 1971-09-08 1974-12-31 Upjohn Co 6-phenyl-1h,4h-{8 1,2,4{9 oxadiazalo{8 4,3-2{9 {8 1,4{9 benzodiazepin-1-ones
US3850948A (en) * 1973-07-27 1974-11-26 Hoffmann La Roche Certain 3a,4-dihydro-8-chloro-6-phenyl-thiazolo(3,2-h)-1,4-benzodiazepin-1(2h)-ones
US3962440A (en) * 1973-12-26 1976-06-08 Eli Lilly And Company Quinoxaline compounds as hypnotic agents
US4107303A (en) * 1976-06-24 1978-08-15 E. I. Du Pont De Nemours And Company Antihypertensive hexafluorohydroxyisopropyl benzazepines and benzazocines
US4218448A (en) * 1976-06-24 1980-08-19 E. I. Du Pont De Nemours And Company Antihypertensive polyfluorohydroxyisopropyl bicyclic and tricyclic carbostyrils
DK160941C (da) * 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
US5248679A (en) * 1988-09-09 1993-09-28 Fujisawa Pharmaceutical Co., Ltd. Tricyclic compounds
FR2649701B2 (fr) * 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
EP0705835A1 (de) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione

Also Published As

Publication number Publication date
BR9811056A (pt) 2000-09-05
CN1265109A (zh) 2000-08-30
RU2198889C2 (ru) 2003-02-20
CZ2000194A3 (cs) 2000-05-17
CZ2000294A3 (cs) 2000-05-17
PL195758B1 (pl) 2007-10-31
FR2766487B1 (fr) 1999-08-27
NO314630B1 (no) 2003-04-22
PL338348A1 (en) 2000-10-23
ES2187997T3 (es) 2003-06-16
JP4491131B2 (ja) 2010-06-30
FR2766487A1 (fr) 1999-01-29
IL134192A0 (en) 2001-04-30
CN1122670C (zh) 2003-10-01
CZ289468B6 (cs) 2002-01-16
TW570923B (en) 2004-01-11
AU746193B2 (en) 2002-04-18
JP2002520253A (ja) 2002-07-09
KR100621703B1 (ko) 2006-09-13
WO1999005147A1 (fr) 1999-02-04
ATE226585T1 (de) 2002-11-15
IL134192A (en) 2007-06-17
IL158356A0 (en) 2004-05-12
KR20010022300A (ko) 2001-03-15
HUP0002777A1 (hu) 2001-07-30
PT1000067E (pt) 2003-03-31
DE69808922D1 (de) 2002-11-28
NO20000423L (no) 2000-03-22
ZA986680B (en) 1999-01-27
IL158356A (en) 2006-04-10
SK1142000A3 (en) 2000-08-14
SK285767B6 (sk) 2007-07-06
AU8867698A (en) 1999-02-16
NZ502054A (en) 2002-05-31
NO20000423D0 (no) 2000-01-27
EP1000067B1 (fr) 2002-10-23
HUP0002777A3 (en) 2002-12-28
HU226210B1 (en) 2008-06-30
CA2298974A1 (fr) 1999-02-04
EP1000067A1 (fr) 2000-05-17
DE69808922T2 (de) 2003-08-14
US6369221B1 (en) 2002-04-09
CA2298974C (fr) 2008-04-01

Similar Documents

Publication Publication Date Title
SE9901875D0 (sv) Novel compounds
SE0104140D0 (sv) Novel Compounds
SE9904652D0 (sv) Novel Compounds
SE9904505D0 (sv) Novel compounds
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
SE9904738D0 (sv) Novel compounds
BR0112030A (pt) Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor
HUT76511A (en) Benzoyl derivatives, preparation and use thereot
SE0200920D0 (sv) Novel compounds
SE0103836D0 (sv) Novel compounds
DK611686D0 (da) Pyrazolinderivater, fremgangsmaade til fremstilling deraf og deres anvendelse som middel med insekticid og akaricid virkning
SE9804212D0 (sv) Compounds
SE0101038D0 (sv) Novel compounds
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
DK1000067T3 (da) Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne
NO904576D0 (no) Aminopyridinylaminofenol og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstilling og anvendelse som medikamenter.
NO20000199D0 (no) Medikamenter inneholdende polyhydroksybutylpyraziner, nye polyhydroksybutylpyraziner og deres fremstilling
NO992731L (no) Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav
SE9904128D0 (sv) Novel compounds
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
ATE293635T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
MXPA03009723A (es) Procedimientos e intermediarios para preparar epoxidos substituidos de bencilo.
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
DK0772579T3 (da) Benzoylderivater og syntese deraf